TTY Biopharm Company Limited (TPEX:4105)
76.80
+1.60 (2.13%)
Jul 23, 2025, 2:31 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cancer Drugs | 2.40B | Log In | Log In | Log In | Log In | Upgrade |
Cancer Drugs Growth | -1.21% | Log In | Log In | Log In | Log In | Upgrade |
Anti-infective Drugs | 1.22B | Log In | Log In | Log In | Log In | Upgrade |
Anti-infective Drugs Growth | 20.35% | Log In | Log In | Log In | Log In | Upgrade |
Investment | 1.12B | Log In | Log In | Log In | Log In | Upgrade |
Investment Growth | 37.00% | Log In | Log In | Log In | Log In | Upgrade |
Export Sales and OEM | 936.49M | Log In | Log In | Log In | Log In | Upgrade |
Export Sales and OEM Growth | 17.55% | Log In | Log In | Log In | Log In | Upgrade |
Medical Insurance | 186.34M | Log In | Log In | Log In | Log In | Upgrade |
Medical Insurance Growth | -51.71% | Log In | Log In | Log In | Log In | Upgrade |
Other | 35.23M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -46.16% | Log In | Log In | Log In | Log In | Upgrade |
Critical Care | - | Log In | Log In | Log In | Log In | Upgrade |
Critical Care Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Gastrointestinal Drugs | - | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Gastrointestinal Drugs Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Taiwan | 5.12B | Log In | Log In | Log In | Log In | Upgrade |
Taiwan Growth | 5.78% | Log In | Log In | Log In | Log In | Upgrade |
Other Countries | 391.78M | Log In | Log In | Log In | Log In | Upgrade |
Other Countries Growth | -1.73% | Log In | Log In | Log In | Log In | Upgrade |
America | 381.29M | Log In | Log In | Log In | Log In | Upgrade |
America Growth | 43.50% | Log In | Log In | Log In | Log In | Upgrade |
Europe | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |